| Amphetamine toxicities: classical and emerging mechanisms BK Yamamoto, A Moszczynska, GA Gudelsky Annals of the New York Academy of Sciences 1187 (1), 101-121, 2010 | 334 | 2010 |
| Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor FJS Lee, L Pei, A Moszczynska, B Vukusic, PJ Fletcher, F Liu The EMBO journal 26 (8), 2127-2136, 2007 | 285 | 2007 |
| Development of primers for the mitochondrial cytochrome c oxidase I gene in digenetic trematodes (Platyhelminthes) illustrates the challenge of barcoding … A Moszczynska, SA Locke, JD McLaughlin, DJ Marcogliese, TJ Crease Molecular Ecology Resources 9, 75-82, 2009 | 281 | 2009 |
| Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors L Pei, FJS Lee, A Moszczynska, B Vukusic, F Liu Journal of Neuroscience 24 (5), 1149-1158, 2004 | 222 | 2004 |
| Why is parkinsonism not a feature of human methamphetamine users? A Moszczynska, P Fitzmaurice, L Ang, KS Kalasinsky, GA Schmunk, ... Brain 127 (2), 363-370, 2004 | 192 | 2004 |
| Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia BM Ross, S Turenne, A Moszczynska, JJ Warsh, SJ Kish Brain research 821 (2), 407-413, 1999 | 163 | 1999 |
| Phospholipid‐Metabolizing Enzymes in Alzheimer's Disease: Increased Lysophospholipid Acyltransferase Activity and Decreased Phospholipase A2 Activity BM Ross, A Moszczynska, J Erlich, SJ Kish Journal of neurochemistry 70 (2), 786-793, 1998 | 142 | 1998 |
| Molecular, behavioral, and physiological consequences of methamphetamine neurotoxicity: implications for treatment A Moszczynska, SP Callan Journal of pharmacology and experimental therapeutics 362 (3), 474-488, 2017 | 138 | 2017 |
| Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users JN Worsley, A Moszczynska, P Falardeau, KS Kalasinsky, G Schmunk, ... Molecular psychiatry 5 (6), 664-672, 2000 | 96 | 2000 |
| Brain antioxidant systems in human methamphetamine users A Moszczynska, P Fitzmaurice, L Ang, KS Kalasinsky, FJ Peretti, SS Aiken, ... Journal of neurochemistry 89 (6), 1396-1408, 2004 | 89 | 2004 |
| Phospholipid biosynthetic enzymes in human brain BM Ross, A Moszczynska, JK Blusztajn, A Sherwin, A Lozano, SJ Kish Lipids 32, 351-358, 1997 | 80 | 1997 |
| Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease BM Ross, N Mamalias, A Moszczynska, AH Rajput, SJ Kish Neuroscience 102 (4), 899-904, 2001 | 72 | 2001 |
| Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine A Moszczynska, S Turenne, SJ Kish Neuroscience letters 255 (1), 49-52, 1998 | 72 | 1998 |
| Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures D Luong, P Kesharwani, BA Killinger, A Moszczynska, FH Sarkar, ... Journal of colloid and interface science 484, 33-43, 2016 | 65 | 2016 |
| Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo A Moszczynska, BK Yamamoto Journal of neurochemistry 116 (6), 1005-1017, 2011 | 61 | 2011 |
| In vitro and in vivo delivery of siRNA via VIPER polymer system to lung cells DP Feldmann, Y Cheng, R Kandil, Y Xie, M Mohammadi, H Harz, ... Journal of controlled release 276, 50-58, 2018 | 57 | 2018 |
| Parkin disrupts the α-synuclein/dopamine transporter interaction: consequences toward dopamine-induced toxicity A Moszczynska, J Saleh, H Zhang, B Vukusic, FJS Lee, F Liu Journal of molecular neuroscience 32, 217-227, 2007 | 57 | 2007 |
| Do glutathione levels decline in aging human brain? J Tong, PS Fitzmaurice, A Moszczynska, K Mattina, LC Ang, I Boileau, ... Free Radical Biology and Medicine 93, 110-117, 2016 | 53 | 2016 |
| Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine BM Ross, A Moszczynska, FJ Peretti, V Adams, GA Schmunk, ... Drug and alcohol dependence 67 (1), 73-79, 2002 | 49 | 2002 |
| Low activity of key phospholipid catabolic and anabolic enzymes in human substantia nigra: possible implications for Parkinson's disease BM Ross, A Moszczynska, J Erlich, SJ Kish Neuroscience 83 (3), 791-798, 1998 | 47 | 1998 |
